We are live on
!
Find out more
Marshall Wace Portfolio holdings
AUM
$100B
1-Year Est. Return
35.1%
This Fund
S&P 500
This Quarter
Est. Return
+8.27%
1 Year Est. Return
+35.1%
3 Year Est. Return
+111.04%
5 Year Est. Return
+146.93%
10 Year Est. Return
+631.22%
AUM
$21.8B
AUM Growth
+$3.36B
(+18%)
Cap. Flow
+$2.78B
Cap. Flow
% of AUM
12.74%
Top 10 Holdings %
Top 10 Hldgs %
12.04%
Holding
3,109
New
1,280
Increased
559
Reduced
519
Closed
699
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
PARA
Paramount Global Class B
PARA
|
+$363M |
| 2 |
Tencent Music
TME
|
+$184M |
| 3 |
FTCH
Farfetch Limited Class A Ordinary Shares
FTCH
|
+$182M |
| 4 |
Baidu
BIDU
|
+$146M |
| 5 |
Gaotu Techedu
GOTU
|
+$139M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Thermo Fisher Scientific
TMO
|
+$204M |
| 2 |
Carnival Corporation Ltd
CCL
|
+$189M |
| 3 |
Zoetis
ZTS
|
+$182M |
| 4 |
Guardant Health
GH
|
+$136M |
| 5 |
Alphabet (Google) Class A
GOOGL
|
+$122M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 20.03% |
| 2 | Consumer Discretionary | 13.15% |
| 3 | Technology | 10.68% |
| 4 | Financials | 9.81% |
| 5 | Communication Services | 8.69% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
ORC
476
Orchid Island Capital
ORC
$1.31B
| $9.6M | 0.04% |
+319,405
| New | +$8.96M |
|
|
ARRWU
477
DELISTED
Arrowroot Acquisition Corp. Unit
ARRWU
| $9.5M | 0.04% |
+955,795
| New | +$9.54M |
|
478
Linde
LIN
$235B
| $9.49M | 0.04% |
33,856
-86,881
| -72% | -$22.5M |
|
479
TSMC
TSM
$2.04T
| $9.48M | 0.04% |
80,144
+33,555
| +72% | +$4.16M |
|
|
GRUB
480
DELISTED
Just Eat Takeaway.com N.V. American Depositary Shares
GRUB
| $9.47M | 0.04% |
78,891
-3,446
| -4% | -$479K |
|
481
Blue Owl Capital
OWL
$6.51B
| $9.45M | 0.04% |
955,961
+205,973
| +27% | +$2.13M |
|
482
Spyre Therapeutics
SYRE
$8.71B
| $9.44M | 0.04% |
47,650
-2,080
| -4% | -$399K |
|
|
CVIIU
483
DELISTED
Churchill Capital Corp VII Units
CVIIU
| $9.44M | 0.04% |
+946,337
| New | +$9.77M |
|
484
AstraZeneca
AZN
$267B
| $9.43M | 0.04% |
94,873
+79,151
| +503% | +$7.96M |
|
485
PUT
State Street SPDR Dow Jones Industrial Average ETF Trust
DIA
$45.5B
| $9.34M | 0.04% |
28,300
-143,000
| -83% | -$45.1M |
|
|
FTOCW
486
CALL
DELISTED
FTAC Olympus Acquisition Corp. Warrant
FTOCW
| $9.34M | 0.04% |
883,252
+349,921
| +66% | +$943K |
|
|
SBNY
487
DELISTED
Signature Bank
SBNY
| $9.33M | 0.04% |
41,284
+13,127
| +47% | +$2.59M |
|
|
DRE
488
DELISTED
Duke Realty Corp.
DRE
| $9.29M | 0.04% |
+221,558
| New | +$8.94M |
|
489
PUT
State Street SPDR S&P Regional Banking ETF
KRE
$4.5B
| $9.29M | 0.04% |
+140,000
| New | +$8.74M |
|
490
CALL
iShares Expanded Tech-Software Sector ETF
IGV
$12.2B
| $9.25M | 0.04% |
+135,500
| New | +$9.61M |
|
491
HubSpot
HUBS
$11.4B
| $9.24M | 0.04% |
20,348
+17,818
| +704% | +$7.83M |
|
492
New Fortress Energy
NFE
$95.4M
| $9.23M | 0.04% |
+201,054
| New | +$9.84M |
|
493
CrowdStrike
CRWD
$187B
| $9.23M | 0.04% |
202,204
+157,040
| +348% | +$8.31M |
|
494
PENN Entertainment
PENN
$2.83B
| $9.22M | 0.04% |
87,899
-2,163
| -2% | -$240K |
|
495
FuboTV Inc
FUBO
$255M
| $9.21M | 0.04% |
+34,694
| New | +$14.9M |
|
496
Novavax
NVAX
$1.25B
| $9.2M | 0.04% |
50,758
+47,881
| +1,664% | +$9.54M |
|
497
Moderna
MRNA
$22.1B
| $9.19M | 0.04% |
70,167
-182,117
| -72% | -$26.4M |
|
|
DOMA
498
DELISTED
Doma Holdings, Inc.
DOMA
| $9.17M | 0.04% |
+36,334
| New | +$9.24M |
|
|
HGEN
499
DELISTED
HUMANIGEN, INC.
HGEN
| $9.17M | 0.04% |
+480,268
| New | +$8.77M |
|
|
KURIU
500
DELISTED
Alkuri Global Acquisition Corp Unit
KURIU
| $9.17M | 0.04% |
+928,364
| New | +$9.47M |
|
Similar funds
Marshall Wace's Q1 2021 Portfolio in Review
As of Q1 2021, Marshall Wace held 3,109 positions worth $21.8B, up 18% from $18.5B the previous quarter. Its ten largest holdings account for 12% of the portfolio.
Marshall Wace deployed $2.78B of net new capital in Q1 2021, opening 1,280 new positions and adding to 559 existing holdings. Its largest new stake was Paramount Global Class B: 5,936,494 shares worth $268M.
By sector, the portfolio is most concentrated in Healthcare at 20% of assets, down from 28% a quarter earlier, followed by Consumer Discretionary and Technology.
On the sell side, the largest reduction was Thermo Fisher Scientific, an estimated $204M trimmed.
- Marshall Wace's largest Q1 2021 buy was Paramount Global Class B: 5,936,494 shares worth $268M.
- Marshall Wace added most to Farfetch Limited Class A Ordinary Shares in Q1 2021, an estimated $182M increase.
- Marshall Wace's biggest Q1 2021 reduction was Thermo Fisher Scientific, cutting an estimated $204M.
- Marshall Wace fully exited Vanguard Intermediate-Term Corporate Bond ETF in Q1 2021, selling an estimated $76.2M.
- Marshall Wace's ten largest holdings make up 12% of its $21.8B portfolio in Q1 2021.
- Marshall Wace opened 1,280 new positions and closed 699 in Q1 2021.
- Marshall Wace's portfolio value rose 18% quarter-over-quarter to $21.8B.
Based on Marshall Wace's 13F filing for Q1 2021, filed 17 May 2021.